These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1126 related items for PubMed ID: 26678406

  • 1. A Novel Tool for Predicting Major Complications After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy.
    Baumgartner JM, Kwong TG, Ma GL, Messer K, Kelly KJ, Lowy AM.
    Ann Surg Oncol; 2016 May; 23(5):1609-17. PubMed ID: 26678406
    [Abstract] [Full Text] [Related]

  • 2. Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Baumgartner JM, Tobin L, Heavey SF, Kelly KJ, Roeland EJ, Lowy AM.
    Ann Surg Oncol; 2015 May; 22(5):1716-21. PubMed ID: 25145504
    [Abstract] [Full Text] [Related]

  • 3. A comparative analysis of postoperative pancreatic fistulas after surgery with and without hyperthermic intraperitoneal chemoperfusion.
    Downs-Canner S, Ding Y, Magge DR, Jones H, Ramalingam L, Zureikat A, Holtzman M, Ahrendt S, Pingpank J, Zeh HJ, Bartlett DL, Choudry HA.
    Ann Surg Oncol; 2015 May; 22(5):1651-7. PubMed ID: 25348781
    [Abstract] [Full Text] [Related]

  • 4. Factors Associated with Readmission After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis.
    Martin AS, Abbott DE, Hanseman D, Sussman JE, Kenkel A, Greiwe P, Saeed N, Ahmad SH, Sussman JJ, Ahmad SA.
    Ann Surg Oncol; 2016 Jun; 23(6):1941-7. PubMed ID: 26842489
    [Abstract] [Full Text] [Related]

  • 5. Repeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with recurrent peritoneal carcinomatosis.
    Vassos N, Förtsch T, Aladashvili A, Hohenberger W, Croner RS.
    World J Surg Oncol; 2016 Feb 24; 14(1):42. PubMed ID: 26912149
    [Abstract] [Full Text] [Related]

  • 6. Enterocutaneous fistula in patients with peritoneal malignancy following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Incidence, management and outcomes.
    Valle SJ, Alzahrani N, Alzahrani S, Traiki TB, Liauw W, Morris DL.
    Surg Oncol; 2016 Sep 24; 25(3):315-20. PubMed ID: 27566038
    [Abstract] [Full Text] [Related]

  • 7. Splenectomy Increases Postoperative Complications Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
    Dagbert F, Thievenaz R, Decullier E, Bakrin N, Cotte E, Rousset P, Vaudoyer D, Passot G, Glehen O.
    Ann Surg Oncol; 2016 Jun 24; 23(6):1980-5. PubMed ID: 26913716
    [Abstract] [Full Text] [Related]

  • 8. Peritoneal cancer patients not suitable for cytoreductive surgery and HIPEC during explorative surgery: risk factors, treatment options, and prognosis.
    van Oudheusden TR, Braam HJ, Luyer MD, Wiezer MJ, van Ramshorst B, Nienhuijs SW, de Hingh IH.
    Ann Surg Oncol; 2015 Apr 24; 22(4):1236-42. PubMed ID: 25319584
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Laparoscopy is Safe and Accurate to Evaluate Peritoneal Surface Metastasis Prior to Cytoreductive Surgery.
    Marmor RA, Kelly KJ, Lowy AM, Baumgartner JM.
    Ann Surg Oncol; 2016 May 24; 23(5):1461-7. PubMed ID: 26542584
    [Abstract] [Full Text] [Related]

  • 12. Extreme cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Outcomes from a single tertiary center.
    Berger Y, Aycart S, Mandeli JP, Heskel M, Sarpel U, Labow DM.
    Surg Oncol; 2015 Sep 24; 24(3):264-9. PubMed ID: 26143715
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Predictors of Severe Morbidity After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Patients With Colorectal Peritoneal Carcinomatosis.
    Simkens GA, van Oudheusden TR, Luyer MD, Nienhuijs SW, Nieuwenhuijzen GA, Rutten HJ, de Hingh IH.
    Ann Surg Oncol; 2016 Mar 24; 23(3):833-41. PubMed ID: 26442921
    [Abstract] [Full Text] [Related]

  • 17. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Dissemination from Small Bowel Malignancy: Results from a Single Specialized Center.
    Liu Y, Ishibashi H, Takeshita K, Mizumoto A, Hirano M, Sako S, Takegawa S, Takao N, Ichinose M, Yonemura Y.
    Ann Surg Oncol; 2016 May 24; 23(5):1625-31. PubMed ID: 26717938
    [Abstract] [Full Text] [Related]

  • 18. Predictive and prognostic survival factors in peritoneal carcinomatosis from appendiceal cancer after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.
    Jimenez W, Sardi A, Nieroda C, Sittig M, Milovanov V, Nunez M, Aydin N, Gushchin V.
    Ann Surg Oncol; 2014 Dec 24; 21(13):4218-25. PubMed ID: 24986239
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 57.